Scarica l'app Stockscreener
46.92
0.90%
0.42
Pre-mercato:
47.27
0.35
+0.75%
Precedente Chiudi:
$46.50
Aprire:
$47.35
Volume 24 ore:
2.31M
Relative Volume:
1.62
Capitalizzazione di mercato:
$10.08B
Reddito:
$1.98B
Utile/perdita netta:
$83.59M
Rapporto P/E:
125.45
EPS:
0.374
Flusso di cassa netto:
$502.31M
1 W Prestazione:
-3.97%
1M Prestazione:
-6.05%
6M Prestazione:
+22.19%
1 anno Prestazione:
-0.20%
Intervallo 1D:
$46.62
$47.38
Intervallo di 1 settimana:
$45.81
$48.73
Portata 52W:
$37.74
$51.88
Qiagen Nv Stock (QGEN) Company Profile
Nome
Qiagen Nv
Settore
Industria
Telefono
-
Indirizzo
-
Confronta QGEN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
46.92 | 10.08B | 1.98B | 83.59M | 502.31M | 0.374 |
|
TMO
Thermo Fisher Scientific Inc
|
487.53 | 186.06B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
203.79 | 147.38B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
639.45 | 51.77B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
125.21 | 35.62B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
183.74 | 32.44B | 15.70B | 1.24B | 2.01B | 6.91 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-24 | Iniziato | Barclays | Overweight |
| 2025-04-04 | Downgrade | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-10-17 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-06-27 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2023-12-07 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-09-12 | Iniziato | Robert W. Baird | Outperform |
| 2023-05-23 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-01-18 | Aggiornamento | DZ Bank | Hold → Buy |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-10-14 | Iniziato | Redburn | Buy |
| 2021-07-14 | Downgrade | Kepler | Buy → Hold |
| 2021-06-03 | Iniziato | Goldman | Neutral |
| 2020-10-06 | Ripresa | BofA Securities | Buy |
| 2020-09-28 | Aggiornamento | Kepler | Hold → Buy |
| 2020-08-24 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-08-20 | Ripresa | JP Morgan | Overweight |
| 2020-08-17 | Aggiornamento | Berenberg | Hold → Buy |
| 2020-08-14 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-08-14 | Aggiornamento | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | Downgrade | Berenberg | Buy → Hold |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Neutral |
| 2019-12-26 | Ripresa | BofA/Merrill | Underperform |
| 2019-11-15 | Iniziato | Stifel | Hold |
| 2019-11-14 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-11-14 | Aggiornamento | JP Morgan | Underweight → Overweight |
| 2019-11-14 | Aggiornamento | Kepler | Reduce → Hold |
| 2019-10-17 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | Downgrade | Kepler | Hold → Reduce |
| 2019-10-08 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-10-08 | Downgrade | Deutsche Bank | Buy → Hold |
| 2019-10-08 | Downgrade | JP Morgan | Neutral → Underweight |
Mostra tutto
Qiagen Nv Borsa (QGEN) Ultime notizie
When is the best time to exit Qiagen N.V.2025 Market WrapUp & Expert Approved Trade Ideas - Newser
Analyzing recovery setups for Qiagen N.V. investors2025 Earnings Impact & Weekly Market Pulse Updates - Newser
Earnings visualization tools for Qiagen N.V.Market Activity Recap & AI Optimized Trade Strategies - Newser
Qiagen N.V. stock prediction for this weekEarnings Overview Report & Low Risk High Win Rate Picks - Newser
Chart based analysis of Qiagen N.V. trendsJuly 2025 Short Interest & Proven Capital Preservation Methods - Newser
What’s next for Qiagen N.V. stockJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - خودرو بانک
Can Qiagen N.V. expand into new marketsJuly 2025 Fed Impact & Verified Stock Trade Ideas - خودرو بانک
QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing - sharewise.com
Qiagen N.V.’s volatility index tracking explainedWeekly Trend Recap & Smart Money Movement Tracker - Newser
Qiagen’s Voting Rights Announcement Involves BlackRock’s Significant Holdings - MSN
Qiagen's (NYSE:QGEN) Strong Earnings Are Of Good Quality - simplywall.st
Hemato-Oncology Testing Market Size, Share & Trends Analysis Report 2025-2030 Featuring Key Players Roche, Abbott, EntroGen, Qiagen, and Cepheid (Danaher) Among Others - uk.finance.yahoo.com
Qiagen shares rise 1.53% premarket after FDA clearance of higher-throughput QIAstat-Dx Rise system. - AInvest
Is Qiagen N.V. forming a bullish divergenceM&A Rumor & Smart Allocation Stock Reports - خودرو بانک
QIAGEN N.V. Launches QIAstat-Dx Rise, a High-Throughput Automated Syndromic Testing System with FDA Clearance. - AInvest
How does Qiagen N.V. score in quality rankings2025 Top Decliners & Long-Term Safe Return Strategies - خودرو بانک
How to escape a deep drawdown in Qiagen N.V.July 2025 Earnings & Risk Adjusted Buy and Sell Alerts - Newser
QIAGEN receives FDA clearance for higher-throughput diagnostic system - StreetInsider
Qiagen Says US FDA Clears Syndromic Testing System - 富途牛牛
US FDA Clears Qiagen's Syndromic Testing System - AInvest
Qiagen Gains US Clearance for Higher-Throughput QIAstat-Dx Rise - AInvest
QIAGEN Introduces QIAstat-Dx Rise: A Higher-Throughput Automated Syndromic Testing System Cleared by FDA. - AInvest
Qiagen gains U.S. clearance of higher-throughput QIAstat-Dx Rise - MarketScreener
160 Tests Per Day: QIAGEN's New QIAstat-Dx Rise System Receives FDA Clearance for Rapid Diagnostics - Stock Titan
Is Qiagen N.V. currently under institutional pressureWeekly Profit Analysis & Technical Entry and Exit Alerts - خودرو بانک
Does Qiagen N.V. have a sustainable dividend2025 Trading Volume Trends & AI Driven Price Predictions - خودرو بانک
Real time pattern detection on Qiagen N.V. stockJuly 2025 Sentiment & Verified Momentum Watchlists - Newser
Qiagen grabbed 'opportunistic window' to sell $750m CB - GlobalCapital
Can Qiagen N.V. be the next market leaderJuly 2025 Update & Daily Growth Stock Tips - خودرو بانک
Does Qiagen N.V. meet Warren Buffett’s criteriaJuly 2025 Summary & Risk Managed Trade Strategies - خودرو بانک
Sentiment analysis tools applied to Qiagen N.V.2025 Year in Review & Verified Chart Pattern Signals - Newser
Trend Dashboard Flags Qiagen N.V. As Potential Swing Trade getLinesFromResByArray error: size == 0 - kangso.co.kr
Multi asset correlation models including Qiagen N.V.Market Performance Summary & Risk Controlled Swing Alerts - Newser
Can swing trading help recover from Qiagen N.V. lossesWeekly Volume Report & Growth Focused Investment Plans - Newser
What Fibonacci levels say about Qiagen N.V. reboundSell Signal & Free Weekly Chart Analysis and Trade Guides - Newser
Qiagen N.V. stock trend forecastWeekly Trend Summary & Safe Capital Investment Plans - Newser
Will Qiagen N.V. stock go up soonTrade Volume Report & Free Weekly Chart Analysis and Trade Guides - Newser
Does Qiagen N.V. qualify in momentum factor screeningBond Market & Long-Term Safe Investment Plans - Newser
What is the next catalyst for Qiagen N.V.Weekly Investment Recap & Risk Managed Investment Strategies - sundaytimes.kr
Qiagen Nv Azioni (QGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.76%
0.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):